← Back to All US Stocks

FCHS Stock Analysis 2026 - First Choice Healthcare Solutions, Inc. AI Rating

FCHS OTC Services-Medical Laboratories DE CIK: 0001416876
Recently Updated • Analysis: Mar 24, 2026 • SEC Data: 2025-12-31
STRONG SELL
98% Conf
Pending
Analysis scheduled

📊 FCHS Key Takeaways

Revenue: $784.5K
Net Margin: -887.4%
Free Cash Flow: $-2.2M
Current Ratio: 0.00x
Debt/Equity: N/A
EPS: $-0.21
AI Rating: STRONG SELL with 98% confidence

Is FCHS a Good Investment? Thesis Analysis

Claude

First Choice Healthcare Solutions is in severe financial distress with negative stockholders' equity of -$39.6M, indicating the company is technically insolvent. Revenue has collapsed 83.9% YoY to just $784.5K while operating losses exceed -$2.7M, demonstrating fundamental business deterioration rather than temporary headwinds. Negative cash flow of -$2.2M and minimal liquidity (cash of $5.9K) create imminent solvency risk without significant operational or financial restructuring.

Why Buy FCHS? Key Strengths

Claude
  • + Limited downside from current levels given near-total business collapse already reflected in financials
  • + Operates in medical laboratory services sector which has structural demand
  • + Minimal insider selling activity suggests limited management confidence erosion in recent period

FCHS Investment Risks to Consider

Claude
  • ! Negative stockholders' equity of -$39.5M indicates technical insolvency and potential bankruptcy risk
  • ! Revenue decline of 83.9% YoY signals loss of customer base or business model failure
  • ! Cash position of only $5.9K with $43.6M in liabilities creates immediate liquidity crisis and inability to fund operations
  • ! Operating margin of -340.5% shows inability to generate revenue profitably at any scale
  • ! Negative free cash flow of -$2.2M combined with minimal cash on hand suggests runway of weeks to months
  • ! Long-term debt of $2.7M plus operating losses indicate high probability of covenant violations or default

Key Metrics to Watch

Claude
  • * Cash burn rate and runway until insolvency
  • * Revenue stabilization or further decline trajectory
  • * Debt restructuring announcements or covenant violation disclosures
  • * Asset impairment charges and potential bankruptcy filings
  • * Customer retention and contract wins in quarterly updates

FCHS Financial Metrics

Revenue
$784.5K
Net Income
$-7.0M
EPS (Diluted)
$-0.21
Free Cash Flow
$-2.2M
Total Assets
$4.0M
Cash Position
$5.9K

💡 AI Analyst Insight

The current ratio below 1.0x warrants monitoring of short-term liquidity.

FCHS Profitability Ratios

Gross Margin 0.9%
Operating Margin -340.5%
Net Margin -887.4%
ROE N/A
ROA -172.0%
FCF Margin -278.9%

FCHS vs Healthcare Sector

How First Choice Healthcare Solutions, Inc. compares to Healthcare sector averages

Net Margin
FCHS -887.4%
vs
Sector Avg 12.0%
FCHS Sector
ROE
FCHS 0.0%
vs
Sector Avg 15.0%
FCHS Sector
Current Ratio
FCHS 0.0x
vs
Sector Avg 2.0x
FCHS Sector
Debt/Equity
FCHS 0.0x
vs
Sector Avg 0.6x
FCHS Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is FCHS Overvalued or Undervalued?

Based on fundamental analysis, First Choice Healthcare Solutions, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.

Return on Equity
N/A
Sector avg: 15%
Net Profit Margin
-887.4%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
N/A
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

FCHS Balance Sheet & Liquidity

Current Ratio
0.00x
Quick Ratio
0.00x
Debt/Equity
N/A
Debt/Assets
1,076.6%
Interest Coverage
-0.57x
Long-term Debt
$2.7M

FCHS 5-Year Financial Trend & Growth Analysis

FCHS 5-year financial data: Year 2011: Revenue $1.3M, Net Income N/A, EPS N/A. Year 2012: Revenue $3.8M, Net Income N/A, EPS N/A. Year 2013: Revenue $6.5M, Net Income N/A, EPS N/A.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: First Choice Healthcare Solutions, Inc.'s revenue has grown significantly by 399% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.12 indicates the company is currently unprofitable.

FCHS Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
-278.9%
Free cash flow / Revenue

FCHS Quarterly Performance

Quarterly financial performance data for First Choice Healthcare Solutions, Inc. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2014 $259.1K -$183.4K N/A
Q2 2014 $258.7K -$120.4K N/A
Q1 2014 $261.9K -$35.1K N/A
Q2 2013 $260.8K -$105.9K N/A
Q1 2013 $266.7K -$204.4K N/A
Q3 2012 $270.5K -$38.3K $0.00
Q1 2012 $311.2K $27.6K $0.00
Q3 2011 $317.6K -$38.3K $0.00

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

FCHS Capital Allocation

Operating Cash Flow
-$549.0K
Cash generated from operations
Capital Expenditures
$1.6M
Investment in assets
Dividends
None
No dividend program

FCHS SEC 10-K & 10-Q Filing Analysis

Access official SEC EDGAR filings for First Choice Healthcare Solutions, Inc. (CIK: 0001416876)

📋 Recent SEC Filings

Date Form Document Action
Mar 11, 2026 10-K form10-k.htm View →
Feb 13, 2026 S-1/A forms-1a.htm View →
Feb 2, 2026 S-1/A forms-1a.htm View →
Jan 30, 2026 S-1/A forms-1a.htm View →
Jan 27, 2026 S-1/A forms-1a.htm View →

Frequently Asked Questions about FCHS

What is the AI rating for FCHS?

First Choice Healthcare Solutions, Inc. (FCHS) has an AI rating of STRONG SELL with 98% confidence, based on fundamental analysis of SEC EDGAR filings.

What are FCHS's key strengths?

Claude: Limited downside from current levels given near-total business collapse already reflected in financials. Operates in medical laboratory services sector which has structural demand.

What are the risks of investing in FCHS?

Claude: Negative stockholders' equity of -$39.5M indicates technical insolvency and potential bankruptcy risk. Revenue decline of 83.9% YoY signals loss of customer base or business model failure.

What is FCHS's revenue and growth?

First Choice Healthcare Solutions, Inc. reported revenue of $784.5K.

Does FCHS pay dividends?

First Choice Healthcare Solutions, Inc. does not currently pay dividends.

Where can I find FCHS SEC filings?

Official SEC filings for First Choice Healthcare Solutions, Inc. (CIK: 0001416876) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is FCHS's EPS?

First Choice Healthcare Solutions, Inc. has a diluted EPS of $-0.21.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is FCHS a good stock to buy right now?

Based on our AI fundamental analysis in March 2026, First Choice Healthcare Solutions, Inc. has a STRONG SELL rating with 98% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is FCHS stock overvalued or undervalued?

Valuation metrics for FCHS: ROE of N/A (sector avg: 15%), net margin of -887.4% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

Should I buy FCHS stock in 2026?

Our dual AI analysis gives First Choice Healthcare Solutions, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is FCHS's free cash flow?

First Choice Healthcare Solutions, Inc.'s operating cash flow is $-549.0K, with capital expenditures of $1.6M. FCF margin is -278.9%.

How does FCHS compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin -887.4% (avg: 12%), ROE N/A (avg: 15%), current ratio 0.00 (avg: 2).

Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 24, 2026 | Data as of: 2025-12-31 | Powered by Claude AI